Compare Stocks

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BOLT Bolt Biotherapeutics	$1.11 -2.6%	$1.22	$0.84 ▼ $2.03	$42.32M	0.99	121,264 shs	55,034 shs
CZX Canada Zinc Metals	C$0.31 +∞	C$0.31	C$0.22 ▼ C$0.39	C$51.69M	N/A	238,645 shs	118,500 shs
FCR First Capital Realty		C$20.86	C$18.60 ▼ C$22.79	N/A	N/A	468,009 shs	3.04 million shs
SILV SilverCrest Metals	$7.91 +4.4%	$6.17	$0.00 ▼ $0.00	$1.16B	1.31	1.42 million shs	2.08 million shs

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BOLT Bolt Biotherapeutics	+2.70%	-10.24%	-0.87%	+1.79%	-27.85%
CZX Canada Zinc Metals	0.00%	0.00%	0.00%	0.00%	0.00%
FCR First Capital Realty	0.00%	0.00%	0.00%	0.00%	0.00%
SILV SilverCrest Metals	+5.89%	+3.49%	+17.31%	+27.19%	+12.09%

Tiny Biotech Stock Wins $75 Billion Patent (Ad)

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BOLT Bolt Biotherapeutics	1.3867 of 5 stars	3.5	0.0	0.0	0.0	0.0	3.3	1.3
CZX Canada Zinc Metals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SILV SilverCrest Metals	1.2938 of 5 stars	3.2	0.0	0.0	0.0	1.6	0.8	1.3

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BOLT Bolt Biotherapeutics	3.00	Buy	$7.00	530.63% Upside
CZX Canada Zinc Metals	N/A	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	N/A	N/A
SILV SilverCrest Metals	2.33	Hold	$12.83	62.34% Upside

Current Analyst Ratings

Latest SILV, BOLT, CZX, and FCR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/8/2024	SILV SilverCrest Metals	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Outperform ➝ Sector Outperform	$7.00 ➝ $7.50
3/22/2024	BOLT Bolt Biotherapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$8.00

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BOLT Bolt Biotherapeutics	$7.88M	5.37	N/A	N/A	$2.97 per share	0.37
CZX Canada Zinc Metals	N/A	N/A	N/A	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	N/A	N/A	N/A	N/A
SILV SilverCrest Metals	$245.13M	4.74	$0.36 per share	22.05	$1.88 per share	4.20

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BOLT Bolt Biotherapeutics	-$69.20M	-$1.83	N/A	N/A	N/A	-878.58%	-51.18%	-37.81%	5/9/2024 (Estimated)
CZX Canada Zinc Metals	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	5/1/2024 (Confirmed)
SILV SilverCrest Metals	$31.30M	$0.78	13.63	17.18	N/A	38.31%	28.00%	23.61%	5/14/2024 (Estimated)

Latest SILV, BOLT, CZX, and FCR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/1/2024	N/A	FCR First Capital Realty	C$0.29	N/A	-C$0.29	N/A	N/A	N/A
3/21/2024	Q4 2023	BOLT Bolt Biotherapeutics	-$0.47	-$0.47	N/A	-$0.47	$1.97 million	$2.09 million
2/6/2024	Q4 2023	FCR First Capital Realty	C$0.31	C$0.81	+C$0.50	C$0.81	N/A	C$171.18 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BOLT Bolt Biotherapeutics	N/A	N/A	N/A	N/A	N/A
CZX Canada Zinc Metals	N/A	N/A	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	N/A	N/A	N/A
SILV SilverCrest Metals	N/A	N/A	N/A	N/A	N/A

Latest SILV, BOLT, CZX, and FCR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/15/2024	FCR First Capital Realty	Monthly	C$0.07	4.14%	4/29/2024	4/30/2024	5/15/2024
3/15/2024	FCR First Capital Realty	Monthly	C$0.07		3/27/2024	3/28/2024	4/15/2024
2/6/2024	FCR First Capital Realty	Monthly	C$0.07		2/28/2024	2/29/2024	3/15/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BOLT Bolt Biotherapeutics	0.15	5.17	5.17
CZX Canada Zinc Metals	N/A	N/A	N/A
FCR First Capital Realty	N/A	N/A	N/A
SILV SilverCrest Metals	N/A	4.66	2.89

Ownership

Institutional Ownership

Company	Institutional Ownership
BOLT Bolt Biotherapeutics	86.70%
CZX Canada Zinc Metals	N/A
FCR First Capital Realty	N/A
SILV SilverCrest Metals	44.75%

Insider Ownership

Company	Insider Ownership
BOLT Bolt Biotherapeutics	28.40%
CZX Canada Zinc Metals	N/A
FCR First Capital Realty	N/A
SILV SilverCrest Metals	4.07%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BOLT Bolt Biotherapeutics	100	38.13 million	27.30 million	Not Optionable
CZX Canada Zinc Metals	147,000	166.73 million	N/A	Not Optionable
FCR First Capital Realty	N/A	N/A	N/A	Not Optionable
SILV SilverCrest Metals	340	147.06 million	139.87 million	Not Optionable

SILV, BOLT, CZX, and FCR Headlines

Source	Headline
	Inflation Could Stick Around Much Longer. What to Do About It. msn.com - April 16 at 9:54 PM
	SilverCrest Metals' (TSE:SIL) investors will be pleased with their impressive 120% return over the last five years finance.yahoo.com - April 15 at 7:57 AM
	CANADA STOCKS-TSX drifts higher on commodities boost msn.com - April 12 at 8:32 PM
	Scotiabank Increases SilverCrest Metals (NYSEMKT:SILV) Price Target to $7.50 americanbankingnews.com - April 10 at 1:20 AM
	Scotiabank Boosts SilverCrest Metals (NYSEMKT:SILV) Price Target to $7.50 marketbeat.com - April 9 at 9:13 AM
	Monday’s Insider Report: President of this high-flying tech company cashes out $69-million theglobeandmail.com - April 8 at 8:37 AM
	Best Stocks of the Top-Performing ETF of the Past Month zacks.com - April 2 at 12:06 PM
	SilverCrest Metals (NYSEMKT:SILV) Trading Up 1.7% marketbeat.com - March 29 at 12:36 AM
	Results: SilverCrest Metals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates finance.yahoo.com - March 14 at 8:26 AM
	Analysts Offer Insights on Materials Companies: Vox Royalty (VOXR) and SilverCrest Metals (SILV) markets.businessinsider.com - March 12 at 6:29 PM
	Toronto market gains as investors rotate into value stocks msn.com - March 12 at 8:28 AM
	SilverCrest Metals Inc. (AMEX:SILV) Q4 2023 Earnings Call Transcript finance.yahoo.com - March 12 at 8:28 AM
	SilverCrest Shares Jump After Quarterly Earnings Beat marketwatch.com - March 11 at 10:47 AM
	Will SilverCrest Metals Inc. (SILV) Beat Estimates Again in Its Next Earnings Report? zacks.com - February 27 at 1:11 PM
	SilverCrest Provides 2024 Guidance prnewswire.com - February 20 at 4:30 PM
	Analysts Have Conflicting Sentiments on These Materials Companies: SilverCrest Metals (SILV) and B2Gold (BTG) markets.businessinsider.com - January 24 at 2:58 PM
	Analysts Offer Insights on Materials Companies: SilverCrest Metals (SILV) and Alamos Gold (AGI) markets.businessinsider.com - January 12 at 7:38 PM
	Why Investors Shouldn't Be Surprised By SilverCrest Metals Inc.'s (TSE:SIL) Low P/E uk.sports.yahoo.com - November 24 at 7:46 AM
	SilverCrest Metals Third Quarter 2023 Earnings: EPS: US$0.20 (vs US$0.17 in 3Q 2022) finance.yahoo.com - November 10 at 7:32 AM
	SilverCrest Metals Inc. (SILV) Tops Q3 Earnings and Revenue Estimates finance.yahoo.com - November 9 at 12:26 AM
	SilverCrest Metals Reports Third Quarter 2023 Results juniorminingnetwork.com - November 8 at 7:26 PM
	SilverCrest Metals reports Q3 results msn.com - November 8 at 7:26 PM
	SilverCrest Reports Third Quarter 2023 Results finance.yahoo.com - November 8 at 7:26 PM
	Wall Street Analysts Believe SilverCrest Metals Inc. (SILV) Could Rally 39.46%: Here's is How to Trade finance.yahoo.com - November 6 at 1:55 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Intel's Foundry Woes: Sell Signal or Silver Lining Ahead?
April 5, 2024 8:45 AM
View Intel's Foundry Woes: Sell Signal or Silver Lining Ahead?
Silver Soars: Here's How to Gain Exposure
April 10, 2024 7:00 AM
View Silver Soars: Here's How to Gain Exposure
TKO Group Knocks Out WrestleMania Event Record
April 15, 2024 7:20 AM
View TKO Group Knocks Out WrestleMania Event Record
Did You Miss the Gold Rush? Try These 2 Silver Stocks
April 15, 2024 7:10 AM
View Did You Miss the Gold Rush? Try These 2 Silver Stocks

All Headlines

Company Descriptions

Bolt Biotherapeutics

NASDAQ:BOLT

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX

Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.

First Capital Realty

TSE:FCR

SilverCrest Metals

NYSEMKT:SILV

SilverCrest Metals Inc. engages in the acquiring, exploration, and development of precious metal properties in Mexico. The company primarily explores for silver and gold properties. Its focuses on principal property the Las Chispas Mine that consists of 28 concessions totaling of approximately 1,401 hectares located in Sonora, Mexico, as well as operates a portfolio of El Picacho, Cruz de Mayo, and Angel de Plata properties in Sonora Mexico. The company was incorporated in 2015 and is headquartered in Vancouver, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial